🍽️ beef

AI Engines For more Details: PerplexityKagi LabsYou

  1. Nutritional Benefits: Beef is a rich source of protein, iron, zinc, and B vitamins such as vitamin B12 and niacin. These nutrients are essential for various bodily functions including muscle growth, immune function, and energy metabolism.

  2. High Saturated Fat Content: Beef, especially fattier cuts, can be high in saturated fat, which has been linked to an increased risk of heart disease when consumed in excess. It's recommended to choose leaner cuts of beef and trim visible fat to reduce saturated fat intake.

  3. Potential for Increased Cholesterol Levels: High consumption of saturated fat, commonly found in beef, can contribute to elevated levels of LDL cholesterol (the "bad" cholesterol) in some individuals, which is a risk factor for cardiovascular disease.

  4. Risk of Colon Cancer: Some studies suggest that high intake of red meat, including beef, may be associated with an increased risk of colorectal cancer. The exact mechanisms are not fully understood, but it's believed that compounds formed during the cooking process, such as heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs), may play a role.

  5. Potential Allergen: Beef allergies are relatively uncommon but can occur. Symptoms can range from mild itching and hives to severe reactions such as anaphylaxis.

  6. Impact on Environmental Health: While not a direct health impact on individuals, the production of beef has significant environmental implications, including greenhouse gas emissions, deforestation, and water usage.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of beef On Probiotics

Rank Probiotic Impact
species Escherichia coli Increases

Bacteria Impacted by beef

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Terrabacteria group clade Increases 👪 Source Study
Bacilli class Increases 👶 Source Study
Clostridia class Increases 👶 Source Study
Desulfuribacillia class Increases 👶 Source Study
Dethiobacteria class Increases 👶 Source Study
Erysipelotrichia class Increases 👶 Source Study
Limnochordia class Increases 👶 Source Study
Negativicutes class Increases 👶 Source Study
Thermolithobacteria class Increases 👶 Source Study
Tissierellia class Increases 👶 Source Study
Enterobacteriaceae family Increases 📓 Source Study
Succinivibrionaceae family Increases 📓 Source Study
Atlantibacter genus Increases 👶 Source Study
Buttiauxella genus Increases 👶 Source Study
Candidatus Ishikawaella genus Increases 👶 Source Study
Candidatus Moranella genus Increases 👶 Source Study
Candidatus Phlomobacter genus Increases 👶 Source Study
Candidatus Profftia genus Increases 👶 Source Study
Candidatus Riesia genus Increases 👶 Source Study
Candidatus Schneideria genus Increases 👶 Source Study
Cedecea genus Increases 👶 Source Study
Citrobacter genus Increases 👶 Source Study Pathogen
Cronobacter genus Increases 👶 Source Study
Enterobacter genus Increases 👶 Source Study Urinary and respiratory infections
Entomohabitans genus Increases 👶 Source Study
Franconibacter genus Increases 👶 Source Study
Jejubacter genus Increases 👶 Source Study
Kluyvera genus Increases 👶 Source Study
Kosakonia genus Increases 👶 Source Study
Leclercia genus Increases 👶 Source Study
Lelliottia genus Increases 👶 Source Study
Mangrovibacter genus Increases 👶 Source Study
Metakosakonia genus Increases 👶 Source Study
Phytobacter genus Increases 👶 Source Study
Plesiomonas genus Increases 👶 Source Study
Pluralibacter genus Increases 👶 Source Study
Pseudescherichia genus Increases 👶 Source Study
Pseudocitrobacter genus Increases 👶 Source Study
Ruminobacter genus Increases 👶 Source Study
Salmonella genus Increases 👶 Source Study Pathogen
Scandinavium genus Increases 👶 Source Study
Shigella genus Increases 👶 Source Study Pathogen
Shimwellia genus Increases 👶 Source Study
Siccibacter genus Increases 👶 Source Study
Succinatimonas genus Increases 👶 Source Study
Succinimonas genus Increases 👶 Source Study
Succinivibrio genus Increases 👶 Source Study
Trabulsiella genus Increases 👶 Source Study
Yokenella genus Increases 👶 Source Study
Biostraticola genus Increases 👶 Source Study
Candidatus Regiella genus Increases 👶 Source Study
Gibbsiella genus Increases 👶 Source Study
Klebsiella genus Increases 👶 Source Study Pathogen
Limnobaculum genus Increases 👶 Source Study
Raoultella genus Increases 👶 Source Study
Rosenbergiella genus Increases 👶 Source Study
Anaerobiospirillum genus Increases 📓 Source Study
Escherichia genus Increases 📓 Source Study
Bacillota sensu stricto incertae sedis no rank Increases 👶 Source Study
Enterobacteriaceae incertae sedis no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
Klebsiella/Raoultella group no rank Increases 👶 Source Study
unclassified Bacillota no rank Increases 👶 Source Study
unclassified Enterobacteriaceae no rank Increases 👶 Source Study
unclassified Escherichia no rank Increases 👶 Source Study
Bacillota phylum Increases 📓 Source Study
Anaerobiospirillum succiniciproducens species Increases 👶 Source Study
Anaerobiospirillum thomasii species Increases 👶 Source Study
Escherichia albertii species Increases 👶 Source Study
Escherichia coli species Increases 👶 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Escherichia fergusonii species Increases 👶 Source Study
Escherichia marmotae species Increases 👶 Source Study
Escherichia sp. species Increases 👶 Source Study
Escherichia sp. E4742 species Increases 👶 Source Study
Escherichia sp. MOD1-EC5457 species Increases 👶 Source Study

Impact of beef on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.8 0.6 0.33
ADHD 0.8 0.8
Allergic Rhinitis (Hay Fever) 0.8 -0.8
Allergies 0.8 1 -0.25
Allergy to milk products 1.2 0.6 1
Alopecia (Hair Loss) 0.6 -0.6
Alzheimer's disease 0.8 1.4 -0.75
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.4 1.6 -0.14
Ankylosing spondylitis 1 2 -1
Anorexia Nervosa 0.2 0.8 -3
Antiphospholipid syndrome (APS) 0.6 -0.6
Asthma 1.2 0.6 1
Atrial fibrillation 1.2 0.6 1
Autism 2.4 1.8 0.33
benign prostatic hyperplasia 0.8 -0.8
Bipolar Disorder 0.8 1.6 -1
Brain Trauma 0.8 -0.8
Carcinoma 0.8 -0.8
Celiac Disease 1.2 0.8 0.5
Chronic Fatigue Syndrome 0.6 0.4 0.5
Chronic Kidney Disease 0.6 0.8 -0.33
Chronic Lyme 0.6 -0.6
Chronic Urticaria (Hives) 0.8 -0.8
Coagulation / Micro clot triggering bacteria 1.8 -1.8
Colorectal Cancer 2.2 -2.2
Constipation 1.6 -1.6
COVID-19 0.6 2.6 -3.33
Crohn's Disease 1.4 2.6 -0.86
cystic fibrosis 1 -1
deep vein thrombosis 1.4 -1.4
Depression 1.8 2.4 -0.33
Dermatomyositis 0.6 0.6
Eczema 1.4 -1.4
Endometriosis 2.2 -2.2
Eosinophilic Esophagitis 0.8 0.8
Epilepsy 0.6 1.6 -1.67
Functional constipation / chronic idiopathic constipation 0.6 2.4 -3
gallstone disease (gsd) 0.8 -0.8
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.6 -0.6
Generalized anxiety disorder 1 -1
Gout 0.4 -0.4
Graves' disease 1.4 0.2 6
Hashimoto's thyroiditis 0.2 0.2
Heart Failure 0.2 -0.2
Hidradenitis Suppurativa 0.6 0.6
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.6 -0.6
hyperglycemia 0.8 -0.8
Hyperlipidemia (High Blood Fats) 0.2 0.2
hypersomnia 0.2 -0.2
hypertension (High Blood Pressure 0.2 1.2 -5
IgA nephropathy (IgAN) 0.6 -0.6
Inflammatory Bowel Disease 0.8 2 -1.5
Insomnia 0.6 0.6
Irritable Bowel Syndrome 1 2.2 -1.2
Juvenile idiopathic arthritis 0.6 0.6
Liver Cirrhosis 1.8 -1.8
Long COVID 1.6 2.4 -0.5
Lung Cancer 0.2 0.8 -3
Metabolic Syndrome 1 2.8 -1.8
Mood Disorders 2.6 2.8 -0.08
Multiple Sclerosis 0.6 0.2 2
myasthenia gravis 0.6 0.6
Neuropathy (all types) 0.6 0.6 0
neuropsychiatric disorders (PANDAS, PANS) 0.6 0.2 2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2 -2
Obesity 1 2.6 -1.6
obsessive-compulsive disorder 1.8 -1.8
Osteoarthritis 0.6 0.6 0
Osteoporosis 0.6 0.8 -0.33
Parkinson's Disease 1.8 1 0.8
Polycystic ovary syndrome 1.4 -1.4
Postural orthostatic tachycardia syndrome 0.6 -0.6
Psoriasis 1.2 -1.2
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.8 2 -1.5
Rosacea 0.8 0.8
Schizophrenia 1.2 0.6 1
Sjögren syndrome 1.4 -1.4
Sleep Apnea 1.4 -1.4
Small Intestinal Bacterial Overgrowth (SIBO) 0.6 1.2 -1
Stress / posttraumatic stress disorder 0.6 1 -0.67
Systemic Lupus Erythematosus 0.8 2 -1.5
Type 1 Diabetes 1.2 -1.2
Type 2 Diabetes 1.2 2.6 -1.17
Ulcerative colitis 1.4 2.8 -1
Unhealthy Ageing 0.6 -0.6

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.